Effect of gestational hypercholesterolaemia on omental vasoreactivity, placental enzyme activity and transplacental passage of normal and oxidised fatty acids.
OBJECTIVE
Maternal hypercholesterolaemia during pregnancy increases lipid peroxidation in mothers and fetuses and programs increased susceptibility to atherosclerosis later in life. The objective of this study was to elucidate the role of the placenta in mediating oxidative stress from mother to offspring.


METHODS
Comparison between normo- and hypercholesterolaemic mothers (n = 36 each) and their children.


METHODS
Obstetric wards, hospitals of the University of Naples and Regione Campania.


METHODS
Healthy primiparas delivering by caesarean section.


METHODS
Biochemical measurements of oxidative stress and serum leptin in cord plasma and placenta, immunochemistry of placenta microvessels, and vasoreactivity studies were performed.


METHODS
Oxidative status (i.e. lipid composition and content of oxidised fatty acids, activity of pro- and antioxidant enzymes, immunohistochemical presence of oxidation-specific epitopes) in maternal and cord blood and in placental tissue, as well as vascular reactivity in omental arteries.


RESULTS
Hypercholesterolaemia during pregnancy was associated with extensive changes in fatty acid composition of both maternal and cord blood lipids, sufficient to alter vasoreactivity of omental vessels. Results also indicated that the placenta is not only subject to substantial oxidative stress, but that it may further increase fetal oxidative stress through changes of pro- and antioxidant enzyme activities.


CONCLUSIONS
The placenta plays an important role in both transmitting and enhancing pathogenic effects of gestational hypercholesterolaemia.
Liguori
A
A
Regional Hospital of Pellegrini, Department of Medicine and Division of Cardiology-CCU, ASLNA1, Naples 80100, Italy.
D'Armiento
F P
FP
Palagiano
A
A
Balestrieri
M L
ML
Williams-Ignarro
S
S
de Nigris
F
F
Lerman
L O
LO
D'Amora
M
M
Rienzo
M
M
Fiorito
C
C
Ignarro
L J
LJ
Palinski
W
W
Napoli
C
C
D000328:Adult; D001158:Arteries / Q000502:physiology; D005227:Fatty Acids / Q000008:administration & dosage / Q000737:chemistry*; D005260:Female; D005312:Fetal Blood / Q000737:chemistry; D005865:Gestational Age; D006801:Humans; D006937:Hypercholesterolemia / Q000378:metabolism*; D007150:Immunohistochemistry; D020738:Leptin / Q000378:metabolism; D015227:Lipid Peroxidation / Q000502:physiology; D008055:Lipids / Q000097:blood / Q000737:chemistry; D009119:Muscle Contraction / Q000187:drug effects; D009131:Muscle, Smooth, Vascular / Q000187:drug effects; D009852:Omentum / Q000098:blood supply*; D010084:Oxidation-Reduction; D018384:Oxidative Stress / Q000502:physiology; D010920:Placenta / Q000201:enzymology*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000378:metabolism*; D014662:Vasoconstrictor Agents / Q000494:pharmacology; D014666:Vasomotor System / Q000378:metabolism
D005227:Fatty Acids; D020738:Leptin; D008055:Lipids; D014662:Vasoconstrictor Agents